Michael Cohron Trotter, MD | |
1705 Hospital St, Greenville, MS 38703-3225 | |
(662) 335-6703 | |
(662) 335-6705 |
Full Name | Michael Cohron Trotter |
---|---|
Gender | Male |
Speciality | Thoracic Surgery (cardiothoracic Vascular Surgery) |
Location | 1705 Hospital St, Greenville, Mississippi |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1518964535 | NPI | - | NPPES |
1978477 | Medicaid | LA | |
P00214993 | Other | LA | RR MEDICARE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208G00000X | Thoracic Surgery (cardiothoracic Vascular Surgery) | 07481R (Louisiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Michael Cohron Trotter, MD Po Box 4739, Greenville, MS 38704-4739 Ph: (662) 725-2749 | Michael Cohron Trotter, MD 1705 Hospital St, Greenville, MS 38703-3225 Ph: (662) 335-6703 |
News Archive
Kidney disease patients who are educated about dialysis are more likely to undergo a standard but under-utilized dialysis-related procedure than less knowledgeable patients, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN).
Egalet Corporation today announced positive results from a Category 3 intranasal human abuse liability (HAL) study of Egalet-001, an abuse-deterrent, extended-release, oral morphine formulation in late-stage clinical development for the management of pain severe enough to require daily, around-the-clock opioid treatment and for which alternative treatments are inadequate.
University of Georgia research has provided new clues on surviving to be 100 years old, finding that how we feel about ourselves and our ability to adapt to an accumulation of challenging life experiences may be as or more important than health factors.
The importance of a healthy lifestyle to reduce stress in order to manage risk factors associated with adverse cardiovascular outcomes is emphasised in a Review in this week's edition of The Lancet.
› Verified 2 days ago